Ashwagandha boosts memory and mood in clinical trial

FHS
June 11, 2024
3:01 am

A clinical trial found that acute and 30-day Ashwagandha supplementation improves cognitive function and mood markers, showing significant benefits in memory, attention, and well-being without adverse effects.

Colorado Department of Revenue Natural Medicine Division Listening Sessions: Round 2 – Psychedelic Alpha

*** The third session of the second round of Listening Sessions revisited the subject of cultivation and manufacturing practices. DOR representatives began by reviewing the

January 30, 2024

Cardiac rehabilitation still underutilized despite proven benefits

Announcing a new article publication for Cardiovascular Innovations and Applications journal.

November 23, 2023

Mindbio Completes Final Post Treatment Milestone in Phase 2A Microdosing Depression Clinical Trial | Psychedelic Invest

MindBio Therapeutics Corp. reported that the final milestone in the Company’s Phase 2A Microdosing Depression Clinical Trial, the 6-month post treatment milestone measuring the “severity

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.